SAMI GAUTHIER: Open Payments
NPI 1063053189 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 9 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $44 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Galderma Laboratories, L.P. | 1 | $30 |
| Apellis Pharmaceuticals, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
Products named: REZDIFFRA, INSPIRE, NEMLUVIO, Empaveli, Wegovy, CRENESSITY, WaveWriter Alpha Prime 16, MOUNJARO.
Industry payments across MI — which companies pay providers there.
